IL324890A - מעכבים של ביטוי ו/או תפקוד - Google Patents

מעכבים של ביטוי ו/או תפקוד

Info

Publication number
IL324890A
IL324890A IL324890A IL32489025A IL324890A IL 324890 A IL324890 A IL 324890A IL 324890 A IL324890 A IL 324890A IL 32489025 A IL32489025 A IL 32489025A IL 324890 A IL324890 A IL 324890A
Authority
IL
Israel
Prior art keywords
inhibitors
expression
function
Prior art date
Application number
IL324890A
Other languages
English (en)
Original Assignee
Tangram Therapeutics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2024/064367 external-priority patent/WO2024245930A2/en
Application filed by Tangram Therapeutics Plc filed Critical Tangram Therapeutics Plc
Publication of IL324890A publication Critical patent/IL324890A/he

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering nucleic acids [NA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3212'-O-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3222'-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/33Chemical structure of the base
    • C12N2310/332Abasic residue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/352Nature of the modification linked to the nucleic acid via a carbon atom
    • C12N2310/3521Methyl
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/353Nature of the modification linked to the nucleic acid via an atom other than carbon
    • C12N2310/3533Halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL324890A 2023-05-26 2025-11-24 מעכבים של ביטוי ו/או תפקוד IL324890A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP23175699 2023-05-26
US202463571886P 2024-03-29 2024-03-29
PCT/EP2024/064367 WO2024245930A2 (en) 2023-05-26 2024-05-24 Inhibitors of expression and/or function

Publications (1)

Publication Number Publication Date
IL324890A true IL324890A (he) 2026-01-01

Family

ID=98266406

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324890A IL324890A (he) 2023-05-26 2025-11-24 מעכבים של ביטוי ו/או תפקוד

Country Status (2)

Country Link
AU (1) AU2024279697A1 (he)
IL (1) IL324890A (he)

Also Published As

Publication number Publication date
AU2024279697A1 (en) 2026-01-08

Similar Documents

Publication Publication Date Title
IL325094A (he) מעכבי pi3k-אלפא ושיטות לשימוש בהם
IL299704A (he) תרכובות טטראהידרופיראזולו-פיראזיניל-דיהידרואימידאזולאון או טטראהידרופיראזולו-פירידיניל-דיהידרואימידאזולאון ושיטות לשימוש בהן
IL321357A (he) מעכבי kif18a ושימושים שלהם
IL312348A (he) מעכבי hif-2alpha ושיטות השימוש בו
IL318169A (he) מעכבי Apol1 ושיטות שימוש זהות
IL310812A (he) צורות מוצקות של מעכבי apol1 spirotricyclic ושיטות שימושן
CA3264917A1 (en) KIF18A INHIBITORS AND THEIR USES
IL299700B1 (he) מעכבי kcnt1 ושיטות לשימוש
IL316619A (he) מעכבי pi3kα ושיטות לשימוש בהם
IL299870A (he) מעכבי גורם משלים c3 והשימושים הרפואיים שלהם
IL312466A (he) מעכבי pi3k-אלפא ושיטות להכנה ולשימוש בהם
EP4341254A4 (en) INHIBITORS AND DEGRADERS OF THE PIP4K PROTEIN
IL317288A (he) מעכבי ביטוי ו/או תפקוד
EP4329735A4 (en) KCNT1 INHIBITORS AND METHODS OF USE
IL321255A (he) מעכבי adar1ושיטות לשימוש בהם
EP4119164A4 (en) ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITOR
IL324890A (he) מעכבים של ביטוי ו/או תפקוד
GB202208122D0 (en) Inhibitors of expression and/or function
GB202208124D0 (en) Inhibitors of expression and/or function
IL314164A (he) מעכבים של גורמים משלימים ושימושים בהם
GB202417093D0 (en) Inhibitors of expression and/or function
GB202416131D0 (en) Inhibitors of expression and/or function
GB202411534D0 (en) Inhibitors of expression and/or function
GB202411530D0 (en) Inhibitors of expression and/or function
GB202411529D0 (en) Inhibitors of expression and/or function